RIL
HRMY icon

Rothschild Investment LLC’s Harmony Biosciences HRMY Stock Holding History

Rothschild Investment LLC’s Portfolio HRMY Stock Details HRMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$17K Buy
468
+323
+223% +$10.2K ﹤0.01% 1604
2026
Q1 		$4.06K Sell
145
-74
-34% -$2.43K ﹤0.01% 2167
2025
Q4 		$8.2K Buy
219
+174
+387% +$5.72K ﹤0.01% 1653
2025
Q3 		$1.24K Hold
45
– – ﹤0.01% 2499
2025
Q2 		$1.42K Hold
45
– – ﹤0.01% 2267
2025
Q1 		$1.49K Buy
45
+20
+80% +$717 ﹤0.01% 2084
2024
Q4 		$860 Sell
25
-10
-29% -$344 ﹤0.01% 2297
2024
Q3 		$1.4K Buy
35
+20
+133% +$703 ﹤0.01% 1926
2024
Q2 		$453 Buy
15
+10
+200% +$301 ﹤0.01% 2081
2024
Q1 		$168 Buy
+5
New +$160 ﹤0.01% 1834

Other funds holding HRMY

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
SG Americas Securities
SG Americas Securities New York $179B AUM 65.34% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return
CM
Capital Management Glen Allen, Virginia $666M AUM 17.17% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return
Universal-Beteiligungs- und Servicegesellschaft
Universal-Beteiligungs- und Servicegesellschaft Frankfurt Am Main, Germany $65.4B AUM 39.83% 1-Year Est. Return

Rothschild Investment LLC's HRMY Position: Q2 2026 in Review

Rothschild Investment LLC increased its Harmony Biosciences (HRMY) stake by 223% in Q2 2026, buying an estimated $10.2K and bringing the position to 468 shares worth $17K. The position accounts for ﹤0.01% of the portfolio, ranked #1604.

Rothschild Investment LLC first reported a position in HRMY in Q1 2024 and has held it in 10 quarters since. 120 funds tracked by Wall St. Rank hold HRMY as of Q2 2026.

  • Rothschild Investment LLC held 468 shares of Harmony Biosciences worth $17K as of Q2 2026.
  • Rothschild Investment LLC bought 323 Harmony Biosciences shares in Q2 2026, an estimated $10.2K.
  • Harmony Biosciences made up ﹤0.01% of Rothschild Investment LLC's portfolio in Q2 2026, its #1604 holding.
  • Rothschild Investment LLC first reported a position in Harmony Biosciences in Q1 2024 and has held it in 10 quarters since.
  • 120 funds tracked by Wall St. Rank held Harmony Biosciences as of Q2 2026.

Based on Rothschild Investment LLC's 13F filing for Q2 2026, filed 6 Aug 2026.